Abstract:Prostate cancer (PCa) testing is currently based on measurement of serum prostate-specific antigen levels and digital rectal examination, which are limited by a low predictive value and the adverse effects associated with overdiagnosis and overtreatment. Recent studies have reported that the abnormal expression of microRNAs (miRNAs) is associated with the mechanism underlying the development of PCa. Thus, the aim of the present study was to investigate the effects of miR-30e and its target gene, M3 muscarinic acetylcholine receptor (CHRM3), on the adhesion, migration, invasion and cell cycle distribution of PCa cells via the mitogen-activated protein kinase (MAPK) signaling pathway. The differentially expressed genes were screened in the Gene Expression Omnibus database from a gene expression microarray (GSE55945) of PCa. PCa tissues and adjacent tissues were collected from patients with PCa. The PC-3 and DU145 human PCa cell lines were treated with activator, inhibitor and siRNAs. The effects of miR-30e on cell adhesion, migration, invasion and cell cycle distribution with the involvement of CHRM3 and the MAPK signaling pathway were investigated. The bioinformatics results demonstrated that the CHRM3 gene and the MAKP signaling pathway were involved in the progression of PCa, and has-miR-30e was selected for further study. The levels of miR-30e were significantly downregulated, while the levels of CHRM3 were obviously upregulated in PCa. CHRM3 was verified as a target gene of miR-30e. Upregulation of miR-30e and downregulation of CHRM3 decreased the levels of p-P38, p-extracellular signal-regulated kinase, p-c-Jun N-terminal kinase, p-c-fos and p-c-JUN, cell adhesion, migration and invasion ability, and the number of cells in the S phase, while they increased the number of cells in the G0 and G1 phases. The findings of the present study suggest that miR-30e inhibited the adhesion, migration, invasion and cell cycle entry of PCa cells by suppressing the activation of the MAPK signaling pathway and inhibiting CHRM3 expression. Thus, miR-30e may serve as a candidate target for the treatment of PCa.

Micro-ribonucleic Acid 29b Inhibits Cell Proliferation and Invasion and Enhances Cell Apoptosis and Chemotherapy Effects of Cisplatin Via Targeting of DNMT3b and AKT3 in Prostate Cancer

Nonconserved Mir‐608 Suppresses Prostate Cancer Progression Through RAC2/PAK4/LIMK1 and BCL2L1/caspase‐3 Pathways by Targeting the 3′‐utrs of RAC2/BCL2L1 and the Coding Region of PAK4

Effects of miRNA-29b on Cell Biological Properties in Prostate Cancer

MiR-29a Suppresses Prostate Cell Proliferation and Induces Apoptosis Via KDM5B Protein Regulation.

miR-200b suppresses cell proliferation, migration and enhances chemosensitivity in prostate cancer by regulating Bmi-1.

miR-31-5p Regulates 14-3-3 ɛ to Inhibit Prostate Cancer 22RV1 Cell Survival and Proliferation via PI3K/AKT/Bcl-2 Signaling Pathway.

MicroRNA-107 Inhibits Proliferation of Prostate Cancer Cells by Targeting Cyclin E1.

Inhibitory Effect of Microrna-29C on Proliferation and Invasion of Human Prostate Cancer Cell Line LNCaP

MicroRNA-194 Regulates Cell Viability and Apoptosis by Targeting CDH2 in Prostatic Cancer

Up-regulated Mir-29C Inhibits Cell Proliferation and Glycolysis by Inhibiting SLC2A3 Expression in Prostate Cancer

MicroRNA-302a Suppresses Tumor Cell Proliferation by Inhibiting AKT in Prostate Cancer.

MicroRNA‐487a‐3p Functions As a New Tumor Suppressor in Prostate Cancer by Targeting CCND1

MicroRNA-340 Inhibits Prostate Cancer Cell Proliferation and Metastasis by Targeting the MDM2-p53 Pathway.

MiR-138–5p Inhibits Prostate Cancer Cell Proliferation and Chemoresistance by Targeting APOBEC3B

MicroRNA-29a Functions as a Tumor Suppressor and Increases Cisplatin Sensitivity by Targeting NRAS in Lung Cancer

Downregulation of Microrna-429 Inhibits Cell Proliferation by Targeting P27kip1 in Human Prostate Cancer Cells.

Mir-29B Restrains Cholangiocarcinoma Progression by Relieving DNMT3B-mediated Repression of CDKN2B Expression

Mirna-30A Functions As a Tumor Suppressor by Downregulating Cyclin E2 Expression in Castration-Resistant Prostate Cancer.

MicroRNA-30e Inhibits Adhesion, Migration, Invasion and Cell Cycle Progression of Prostate Cancer Cells Via Inhibition of the Activation of the MAPK Signaling Pathway by Downregulating CHRM3

Suppression of Microrna-454 Impedes the Proliferation and Invasion of Prostate Cancer Cells by Promoting N-myc Downstream-Regulated Gene 2 and Inhibiting WNT/β-catenin Signaling

Mir‑27b‑3p and Mir‑607 Cooperatively Regulate BLM Gene Expression by Directly Targeting the 3'‑UTR in PC3 Cells.